One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 230,000 shares of Pfizer Inc. (NYSE: PFE) on Tuesday, as the price of this fund pulled back over 2% in the day’s session. However, it is up a fair amount in the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) parted with 238,235 shares of Pfizer. At Tuesday’s closing price, this would have valued this sale at roughly $11.3 million. This is only a small fraction of the total holdings. The fund is up about 10% over the past 52 weeks.
Check out all the ARK Invest buys for Tuesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | REGN | REGENERON PHARMACEUTICALS | 17,447 |
| ARKG | PFE | PFIZER | 238,235 |
| ARKG | CSTL | CASTLE BIOSCIENCES | 200 |
| ARKG | CLLS | CELLECTIS | 25,000 |
| ARKK | PRLB | PROTO LABS | 23,707 |
| ARKK | U | UNITY SOFTWARE | 121,968 |
| ARKQ | U | UNITY SOFTWARE | 47,465 |
| ARKW | RBLX | ROBLOX | 82,267 |
| ARKW | U | UNITY SOFTWARE | 33,281 |
| ARKX | U | UNITY SOFTWARE | 5,343 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
24/7 Wall St.Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
